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Liquid chromatography/quadrupole time of flight mass spectrometry (LC/QTOF MS) utiliz-
ing electrospray ionization was employed to monitor protein expression in Escherichia coli and
Shigella organisms. Comparison with MALDI/TOF-MS revealed more proteins, particularly
above 15 kDa. A combination of automated charge state deconvolution, spectral mirroring,
and spectral subtraction was used to reveal subtle differences in the LC/MS data. Reproduc-
ible intact protein biomarker candidates were discovered based on their unique mass,
retention time, and relative intensity. These marker candidates were implemented to differ-
entiate closely related strain types, (e.g., two distinct isolates of E. coli O157:H7) and to
correctly identify unknown pathogens. This LC/MS approach is less labor-intensive than
pulsed-field gel electrophoresis, affords greater specificity than real-time PCR, and requires no
primers or antibodies. Additionally, this approach would be beneficial during outbreaks of
foodborne disease or bioterrorism investigations by complementing methods typically used in
diagnostic microbiology laboratories. (J Am Soc Mass Spectrom 2008, 19, 1621–1628) © 2008
American Society for Mass SpectrometryTwo of the top 10 leading causes of food andwaterborne illness outbreaks reported to the Cen-ters for Disease Control and Prevention from
1972 to 2000 were Shiga toxin producing E. coli (STEC)
and Shigella organisms [1]. The threat of these patho-
gens being used intentionally as biowarfare agents also
exists. STEC and some species of Shigella produce a
toxin that is classified as a Category B select agent and
deliberate use of these bacteria has been documented
[1, 2].
Clinical manifestations (malaise, abdominal pain,
diarrhea etc.) of exposure do not unambiguously iden-
tify their cause. Therefore, analytical methods are
needed to gain further insight. The three most com-
monly used analytical methods in diagnostic microbi-
ology laboratories are enzyme immunoassay (EIA),
real-time polymerase chain reaction (PCR), and pulsed-
field gel electrophoresis (PFGE). EIA methods are sen-
sitive, often eliminating the need for cultural enrich-
ment, but lack the specificity to be considered
confirmatory. Real-time PCR is a rapid and sensitive
approach requiring 0.5 to 4 h postculture to perform.
However, strain-specific and often species-specific
primers are unavailable or impractical and, for this
reason, the specificity required in outbreak investiga-
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doi:10.1016/j.jasms.2008.07.003tions is not typically afforded by this method. An
important consideration is that the mere presence of a
gene does not guarantee that protein is being expressed;
bacterial pathogens have been shown to contain genes
that are not expressed [3–5]. Finally, the gold standard
for providing strain level discrimination of bacteria
during outbreak investigations is PFGE. While this
technique possesses the desired specificity, it is not
easily automated, is labor intensive, and requires a
minimum of 2 d postculture.
Several different reviews on the analysis of bacteria
all had one common conclusion—the strongest ap-
proach is an integrated one combining information
from several different yet complimentary techniques
[6 –9]. The benefit of an integrated approach and the
importance of bacterial pathogens to public health and
homeland security act as a driving force behind the
development of new methods of detection and charac-
terization. The approach described here is unique in
that it utilizes liquid chromatography/mass spectrom-
etry (LC/MS) of intact proteins, to monitor protein
expression in bacterial cells. Key differences between
closely related strains may occur within the proteome to
which genetic approaches are insensitive, e.g., post-
translational modifications (PTMs), making this ap-
proach potentially advantageous.
Since much of the early work regarding the mass
spectrometric analysis of intact bacterial proteins has
involved matrix assisted laser desorption/time of flight
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comparison with this technique was performed. To
examine the efficacy of this approach as a tool in
diagnostic microbiology, a model set of 10 Shigella and
E. coli clinical isolates were studied (Table 1) as a proof
of concept. From these 10 isolates, putative biomarkers
or biomarker candidates were discovered based on
protein mass, retention time, and relative intensity, and
evaluated for their reproducibility by performing five
replicate analyses. Finally, the validity of these putative
markers was challenged by applying them to a blind
test of clinical isolates.
Experimental
Materials and Methods
HPLC grade solvents (acetonitrile, formic acid, and
trifluoroacetic acid) were purchased from Fisher Scien-
tific (Fairlawn, NJ) and 2-propanol was purchased from
Honeywell, Burdick, and Jackson (Morristown, NJ). The
water utilized for HPLC analysis was purified in-house
to yield organic-free 18.3 M  cm using an E-pure
purification system (Barnstead International, Dubuque,
IA). Sterile water that had been autoclaved and purified
with a RiOs 5 Water Purification System (Millipore,
Billerica, MA) was used during bacteria preparation.
Growth and Lysis
Isolates were obtained from the Virginia Division of
Consolidated Laboratory Services. Biosafety level 2
(BSL2) procedures and facilities were utilized for sam-
ple handling and preparation. Trypticase soy agar
plates containing 5% sheep’s blood were used as the
growth medium. Cells were grown for 24 h at a
temperature of 37 °C in the presence of oxygen with 5%
CO2. After this growth period, cells were removed from
the plate and placed in a test tube containing 1 mL of
sterile water until the optical density reading reached
1.0 using a microscan turbidity meter (Dade Behring,
West Sacramento, CA). A 500 L aliquot of this suspen-
sion was washed three times with 500 L of sterile
water followed by centrifugation (6000  g at room
temperature for 5 min) to remove residual media.
Finally, the cells were resuspended in 150 L of the lysis
solution (1:1 organic-free H2O: acetonitrile, 0.1% vol/
Table 1. The 10 known isolates examined in this study
Family
Genus Escheric
Species E. co
Serotype ND (nonpathogenic) O111:NM
Accession number 06-0004 06-1440
06-0006
ND  not determined; NM  nonmotile; NA  not applicable.vol trifluoroacetic acid). After chemical lysis, the samplewas again centrifuged (4100  g for 4 min) at room
temperature. Following centrifugation, 65 L of super-
natant was removed and placed in an autosampler vial
for analysis.
MALDI/TOF-MS
Aliquots (1 L) of (1:1) bacterial cell lysate and sinapinic
acid (30 mg/mL) matrix solution were spotted onto a
stainless steel MALDI target plate and allowed to air
dry. Mass spectra were obtained with a Bruker Dalton-
ics Ultraflex II (Billerica, MA) instrument operating in
linear, positive ion mode. Mass spectra were acquired
utilizing the following instrument parameters: pulsed
ion extraction delay of 300 ns, ion source voltage one, 25
kV, ion source voltage two, 23.25 kV, and ion source
lens voltage 6.20 kV. For each sample, mass spectra
were acquired by accumulating 200 laser shots at 54%
laser power in the m/z range of 4000–40,000 Da.
FlexAnalysis (Bruker Daltonics) software was used
to generate peak lists after background subtraction, peak
centering, and “. . .background subtraction, Gaussian
smoothing, and peak centering.” Data lists containing
m/z values and corresponding peak intensities were
exported as text files before mass spectral comparison
by MS Manager (Advanced Chemistry Development
Laboratories, Toronto, ON).
LC/QTOF MS Analysis
Intact proteins were separated by reversed-phase chro-
matography using an Acquity liquid chromatograph
(Waters, Milford, MA). Gradient elution (5%–55% B in
60 min) was used at a flow rate of 0.225 mL/min, where
A  H2O (1% formic acid) and B  2-propanol (1%
formic acid). The column was a nonporous Prosphere
P-HR 2.1  150 mm, 4 m particle size (Alltech,
Columbia, MD) operated at 50 °C. The autosampler was
maintained at 15 °C before administering the injection
volume of 20 L.
A Q-TOF Premier (Waters) utilizing positive ion
electrospray ionization was used for mass analysis. Ions
were monitored from m/z 620–2450 and resolved in
single reflectron (V) mode. The parameters employed in
the MS method were optimized for sensitivity and
resolution using bovine serum albumin. These values
Enterobacteriaceae
Shigella
S. flexneri S. sonnei
O26:H11 O157:H7 ND NA
06-1418 06-1439 04-0497 06-1362
06-1464 06-0967 06-1364hia
liwere 3.9 kV capillary voltage, 40 V cone voltage,
1623J Am Soc Mass Spectrom 2008, 19, 1621–1628 LC/MS OF INTACT BACTERIAL PROTEINS115 °C source temperature, 500 °C desolvation temper-
ature, and 900 L/h desolvation gas flow.
Data Processing
All LC/MS data were processed using two software
packages: Protrawler6 (BioAnalyte, Portland, ME) and
MS Manager (Advanced Chemistry Development Lab-
oratories). Protrawler6 software provided automated
charge state deconvolution of multiply charged ions by
first dividing the full-scan data from the chromatogram
into time intervals (30 s) and then summing and decon-
voluting the data from each interval. The process was
repeated to obtain neutral masses of the proteins that
eluted during each interval. A text file containing the
neutral masses, intensities, and retention times was
then created summarizing the results for each chro-
matogram [13]. Retention time information can be used
for further study (e.g., fraction collection) of proteins of
interest or to distinguish proteins of the same mass that
differ in retention. The masses and intensities were used
to create a single spectrum representing all of the
proteins observed in the lysate using MS Manager.
To further facilitate biomarker candidate discovery,
MS Manager was employed for spectral mirroring and
spectral subtraction. Spectral mirroring allowed spectra
to be mirrored along the abscissa, placing the baseline at
the center of view. Spectral subtraction removed all
common peaks between two spectra within a given
mass accuracy so that only unique ones remained. For
group and strain level comparisons involving multiple
spectra, the text files of all isolates not in that group or
strain were combined to create a cumulative spectrum,
which was then used for subtraction. A subtraction
window of 2 Da was utilized as a baseline for initial
discovery and then optimized for specific datasets with
larger mass ions (30 kDa).
Results and Discussion
LC/ESI-MS Versus MALDI-TOF/MS Comparison
MALDI-TOF exhibits certain advantages over LC/MS.
One, by producing primarily singly charged ions, data
interpretation is greatly simplified relative to ESI-MS.
MALDI-TOF is also better suited for the analysis of
complex mixtures; therefore prior separation (e.g., chro-
matography) is not required. Consequently, MALDI-
TOF has a considerable throughput advantage2 min/
sample (after deposition and drying) compared with2
h/sample (data acquisition and deconvolution) over
LC/MS.
However, as can be seen in Figure 1, after automated
charge state deconvolution with Protrawler6, spectra
from LC/MS are as simple to interpret as MALDI data,
and contain more high mass information. In addition to
providing more proteins (particularly 15 kDa), other
advantages to using LC/MS exist. These include im-
proved mass resolution and mass accuracy, reproduc-ibility, and more reliable quantitative data. The last two
advantages stem from the uneven distribution of the
sample across the spot on the MALDI target and
variance in the placement and number of laser shots
acquired on the sample.
Having retention time information allows more to be
known about the biomarker candidates. MALDI-TOF
data is analogous to that obtained from a 1D gel, while
LC/MS data is comparable to that acquired from a 2D
gel (with obvious improvements in mass resolution and
mass accuracy over gel-based approaches). The LC/MS
approach also allows for distinctions of proteins of the
same mass that differ in retention time. If the effluent
from the LC is split, simultaneous fraction collection
and MS analysis can be performed, and the collected
fractions can be used for further study (e.g., sequenc-
ing). Protein isolation for further study can not be
performed by MALDI-TOF; either LC or tandem mass
spectrometry would be required.
Figure 1 depicts a comparison of MALDI/TOF and
LC/QTOF data using the same sample preparation and
protein extraction procedures for a S. sonnei isolate.
Reasons for the differences in observed proteins may
include difficulty in optimizing MS conditions over
such a wide m/z range (4000–40,000 Da,   36,000 Da)
with MALDI-TOF compared with (620–2450 Da,  
1830 Da) during ESI. The complexity of the lysate is
another issue that may lead to ion suppression and/or
detector saturation. Other factors such as the matrix and
the acid content of the matrix solution can also play a
role in the observation of higher mass ions [14], and
finding optimal matrix conditions over a wide m/z
range can be challenging. Although the LC step causes
decreased throughput, this step is likely part of the
reason more proteins are observed. Often, distinctions
between closely related strains may involve only one or
a few proteins and, for this reason, the increased
information content and protein yield observed by the
LC/MS approach is likely advantageous and deemed
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Figure 1. Comparison of MALDI/TOF-MS and LC/MS of the
same S. sonnei lysate.worthy of further investigation.
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The word “discovery” here denotes the process of going
from a sample containing hundreds of proteins to a
small list of unique proteins that have potential identi-
fication utility. These proteins are still in the candidacy
phase as they require further validation by examining a
large list of unknowns. Further structural characteriza-
tion of the qualitative candidates to determine whether
they are unique by sequence or by modification may
also prove beneficial. In the first step of discovery,
chromatographic data is collected in full-scan mode.
Next, automated charge state deconvolution is per-
formed to yield a single mass spectrum representing all
of the proteins observed in the chromatogram. The
spectra are then mirrored (Figure 2a) and subtracted,
revealing unique masses (Figure 2b). As seen in Figure
2b, numerous peaks appear to be unique to each iso-
late after subtraction. However, many of these peaks
were not reproducible and may have been artifacts from
the deconvolution process. For this reason, a protein
was deemed a biomarker candidate only if its unique
mass, retention time, and or relative intensity was
observed in each of the five repeated experiments.
Spectra from the 10 isolates listed in Table 1 were
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Figure 2. (a) Integrated mass spectra for all proteins observed
after automated charge state deconvolution for the indicated
serotypes. (b) Results after mass spectral subtraction using a 2
Da window leaving only unique masses for each serotype.examined to find reproducible biomarker candidates
whose presence or absence could be used to identify
unknown samples. To determine the specificity of the
technique, a search for biomarker candidates was made
at each taxonomic level (e.g., species, serotype, and
strain).
Qualitative Markers: Mass and Retention Time
Real-time PCR primers for Shigella speciation are com-
mercially unavailable. However, with LC/MS, distinc-
tions between Shigella species were observed. Figure 3
depicts mirrored and subtracted spectra for S. flexneri
and S. sonnei. The masses in bold marked with asterisks
were found in both isolates of that Shigella species
during each of the five replicate analyses, yet were not
observed in any of the other eight isolates studied.
These species-specific marker candidates also enabled
the genera Escherichia and Shigella to be distinguished,
even though no genus-specific biomarker candidates
were observed. For example, the protein at mass 12,235
was unique to S. sonnei and was therefore not associated
with the species S. flexneri or the genus Escherichia.
The protein at mass 7287 unique to S. flexneri has the
same retention time (26.4 min) and nearly the same
mass as a 7273 Da protein present in all of the E. coli and
S. sonnei isolates studied. This mass difference of 14 Da
could be due to a PTM (e.g., methylation), an amino
acid substitution (e.g., I for V), or some combination of
the two. Either way, such a small difference would
likely go unnoticed in a gel-based approach, or when
using a detector with less specificity such as ultra-violet
or fluorescence spectroscopy.
As an example of serotype differentiation by this
approach, the two E. coli O157:H7 isolates were com-
pared against the other eight isolates. During this
comparison, a protein at mass 18,996 was discovered
unique to this serotype, thereby demonstrating the
ability of this method to distinguish enterohemorrhagic
E. coli (EHEC) serotypes (e.g., O157:H7, O26:H11, and
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Figure 3. Mass spectral comparison of two species of Shigella
treated as in Figure 2. Masses unique to each species are denoted
in bold-type and with an asterisk.O111:NM), which are otherwise indistinguishable by
were
1625J Am Soc Mass Spectrom 2008, 19, 1621–1628 LC/MS OF INTACT BACTERIAL PROTEINSclinical symptoms [15]. Table 2 contains the masses and
retention times for proteins that were found unique to a
group such as to both O157:H7 or to both S. sonnei
isolates etc. Using the experimental conditions de-
scribed here, the proteins listed in Table 2 could be used
to identify unknowns based on their presence or
absence.
The two non-O157:H7 EHEC have peaks that iden-
tify them as a group as well (Table 2), but when each
individual isolate (06-1440 or 06-1418) was compared
against the other nine, no unique peaks were found. It
was suspected, however, that one of the isolates might
share a genetic similarity with some of the other eight
isolates that was not shared with the other non-O157:H7
EHEC. For this reason, the O111:NM (nonmotile) and
O26:H11 spectra were subtracted only against each
other. During this comparison, a protein at 11,779 Da
having a retention time of 27.0 min was found unique to
O111:NM (Figure 2b). A protein of this same mass and
retention time has also been observed in S. flexneri and
E. coliO157:H7 isolates. Accordingly, during a blind test
these two E. coli serotypes could be distinguished first
by looking for the group-specific peaks listed in Table 2,
which would classify them as a non-O157:H7 EHEC,
then observing a protein at 11,779 Da with a retention
time of 27.0 min, which would indicate that the sample
was E. coli O111:NM.
In epidemiological and forensic investigations, tech-
niques that can characterize bacteria at the strain level
are desirable for establishing cluster or outbreak rela-
tionships via strain relatedness. Highly specific charac-
terization is needed to detect and pinpoint the source of
an outbreak, such as a particular produce manufacturer
or suspected bioweapons facility. To this end, strain
level comparisons between E. coliO157:H7 isolates were
made. One O157:H7 isolate studied, accession no. 06-
1464, has shown a reproducible protein at 14,880 Da
eluting at 26.9 min not observed in the other O157:H7
isolate, accession no. 06-1439, or any of the other E. coli
or Shigella samples. The differences observed between
these two O157:H7 isolates indicate that the method
described here is not only capable of identifying bacte-
ria, but also of discerning small phenotypic differences,
which could be indicative of the pathogen’s origin and
growth environment. With the exception of PFGE,
which indicated 98% similarity, other established
techniques (e.g., serology) found these two isolates to be
identical. In addition to the value of establishing strain
Table 2. Group-specific qualitative biomarker candidates. Mass
parentheses
Group E. coli O157:H7 non-O
Unique proteins 18,996 (43.3) 15
24
aMass tolerance of 3 Da.
bProteins that may be quantitative markers. These marker candidatesrelatedness during outbreak investigations, the abilityto distinguish two strains (such as the ones described
above) that while genetically similar are epidemiologi-
cally unrelated is also significant. Figure 4 depicts the
comparison of the two E. coli O157:H7 spectra with
PFGE results in the inset.
Analogous to PFGE, in which sequencing of the
chromosomal fragments is not performed [16], this
approach does not involve sequencing of the biomarker
candidates. The justification is that reproducible bi-
omarker candidates have been observed allowing for
characterization at the strain level without knowing the
actual identity of the proteins involved. Therefore, this
approach could potentially be applied to bacteria whose
genomes have not been sequenced. In contrast, pro-
teomic approaches that rely upon database results for
identification purposes would have little utility for such
bacteria. Finally, circumventing protein sequencing al-
lows the avoidance of a timely digestion step, resulting
in a reduced analysis time.
Distinction of Isobars Differing in Retention
Since proteins with larger quantities of, or more easily
accessible, hydrophobic regions will stay adsorbed to
the column longer [17], retention time can therefore be
used to distinguish two different isobaric proteins. This
is critical when a sample has two or more different
proteins of approximately the same mass. Such was
Da) is listed first followed by retention time (0.5 min) in
H7 EHEC S. flexneri S. sonnei
(27.1)
(38.5)
35,250 (31.4)a,b
16,886 (26.8)
7287 (27.9)b
11,795 (27.3)
12,235 (45.4)
present in all five replicates.
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Figure 4. Strain-level comparison of two E. coli O157:H7 after
treatment as in Figure 2. The gold standard method, PFGE
analysis, determined 98% similarity between the two isolates(2
157:
,478
,315after 48 h (inset).
1626 EVERLEY ET AL. J Am Soc Mass Spectrom 2008, 19, 1621–1628found to be the case for S. flexneri 04-0497. This strain of
S. flexneri has two proteins within 2 Da of mass 18,121
that differ in retention time by nearly 16 min (approx-
imately 13% B at a gradient slope of 0.83% B/min). One
protein that eluted at 37.1 min had been observed in
both E. coliO157:H7 and both S. flexneri isolates studied.
The other protein, however, eluted at 21.3 min and was
present only in S. flexneri 04-0497. This is an example
where techniques providing mass alone (e.g., MALDI/
TOF-MS) can be insufficient to recognize some biomar-
ker candidates.
Quantitative Markers
In addition to qualitative aspects (e.g., mass and reten-
tion time) that signify biomarker candidates, proteins
that differ in intensity are also informative and may be
caused by up or down regulation or possibly genetic
engineering (to produce more toxin etc.). The utility of
quantitative biomarker candidates was evident during
the analysis of the two non-O157:H7 EHECs. In the
other eight samples, the intensity of a protein at 15,406
Da was much greater than one at 15,423 Da, but the
trend was reversed for the two non-O157:H7 EHECs.
Interestingly, this difference involved two of the most
abundant proteins in the lysate and, for this reason, the
quantitative difference was immediately obvious mean-
ing no spectral subtraction of common peaks was
required.
Strain level quantitative differences were also ob-
served. In S. flexneri 04-0497, a protein at mass 9737
eluting at 26.4 min and highly abundant in all nine
other isolates was low in intensity. Additionally, in E.
coli 06-0006, a protein that elutes at 30.6 min weighing
35,171 Da, common to other E. coli and S. sonnei isolates,
is completely absent, most likely underexpressed below
the limit of detection. Alternatively, the gene for this
protein could be damaged or turned off or possibly
absent so that no protein is being expressed at all,
making this a qualitative distinction.
Analysis of Unknowns
To challenge the validity of the biomarker candidates
discussed above, a blind study of 13 isolates distinct
from the original 10 was performed. In an attempt to
identify each unknown, the mass spectra obtained from
each of the 13 isolates were individually screened for
the biomarker candidates listed in Table 2. Upon in-
spection of the blind study data, one initial observation
was shifting retention times for the markers. During the
early investigation of known isolates, a retention time
window of 0.5 min was observed. However, during
the blind study, analyte retention times seemed more
variable, indicating an average window of 1.0 min
was more suitable. Possible explanations for this varia-
tion include degradation of the column or minor differ-
ences in the mobile phase composition. However, this
variation was consistent within each run, thus notaffecting the relative retention times of the analytes.
When used in conjunction, the retention time, mass, and
relative intensity (RI) information (for quantitative
markers) allowed the biomarker candidates to be de-
tected with confidence.
Another observation was made concerning two of
the three biomarker candidates for S. flexneri, one at
7287 and one at 35,250 Da. These proteins have coun-
terparts in E. coli and S. sonnei exhibiting the same
retention times but at decreased masses of 7273 and
35,170 Da. During the blind study, these two S. flexneri
proteins were observed in small amounts (2%–5% RI,
relative to the base peak) in some of the E. coli O157:H7
and S. sonnei isolates. There were a few possible reasons
for this. (1) If the genes encoding these two proteins
reside on extrachromosomal elements, they may have
been horizontally transferred. (2) There may have been
a small amount of S. flexneri present in these samples
and they were therefore technically a mixture. (3) Since
the mass spectrometer displayed higher total ion counts
during the blind study than in any of the five previous
replicates of the known isolates, these low abundance
ions were now within the limit of detection. However,
even with the greater ion counts, the E. coli and S. sonnei
counterparts were not observed in any S. flexneri iso-
lates, and the 16,886 Da S. flexneri marker, which was
the least intense of the three S. flexneri markers (Figure
3), was not observed in any of the non-S. flexneri
isolates. Since the exact reason(s) was not determined,
these two S. flexneri proteins were, at least for the
unknown isolates examined here, best used as quanti-
tative biomarker candidates rather than qualitative.
Using the two S. flexneri proteins as quantitative
markers, all biomarker candidates were present and
absent as expected allowing all 13 unknown isolates to
be correctly identified. In total, there were three S.
sonnei, three S. flexneri, four E. coli O157:H7, one E. coli
O26:H11, and two E. coli O111:NM isolates identified.
Since the reproducibility of the biomarker candidates
had already been established, only a single analysis was
required to correctly identify the unknowns. The time
required to collect, process, and examine the data to
determine the identity of the unknown isolates was
approximately 2 h per sample postculture.
Currently, identification of unknowns by this
method is achieved through association with previ-
ously examined (known) pathogens, and is therefore
limited to the types of pathogens listed in Table 1. For
each type of bacterium that has been studied, an un-
known of that same type can be identified in 2 h
postculture. If a previously unstudied bacterium were
analyzed, e.g., S. boydii, it would likely be recognized as
the Escherichia/Shigella genus. Based on absence of
marker masses, previously studied species, serotypes,
and strains of the Escherichia/Shigella genus would be
eliminated from consideration in 2 h postculture, pro-
viding a general classification of the bacterium.
One potential utility for this method would involve
uploading LC/MS results from various public health
1627J Am Soc Mass Spectrom 2008, 19, 1621–1628 LC/MS OF INTACT BACTERIAL PROTEINSlaboratories into a public database such as PulseNet,
which utilizes PFGE data to detect outbreaks around
the country [18]. Before LC/MS data could be used in
this fashion, the issue of inter- and intralaboratory
variability must be addressed. The first step to address
both types of variability would be the formation of a
standard operating procedure (SOP) document. The
SOP would provide detailed methods and instructions
beginning with cell growth and ending with data anal-
ysis, and would be followed as closely as possible by
partner laboratories. The same LC/MS instrumentation
would not be required but the same LC conditions
(column, gradient, etc.) and a TOF mass analyzer
should be used.
Besides implementing an SOP across laboratories,
another way to address inter- and intralaboratory vari-
ability would be to add a standard protein to the lysate
before analysis. Being a standard, this protein’s mass
and retention time would be well characterized before
use. To address retention time shifts, the biomarker
retention times would not only be reported as0.5 min,
but also as from a system where on average myoglobin
eluted at 32.4 min. For example, if another laboratory
uses a system with more dead volume than the one
described here and myoglobin eluted at 32.9 min, 0.5
min could be subtracted from all of the results in that
laboratory before searching for the biomarkers ob-
served in this laboratory. This standard could also be
utilized as an internal calibrant to correct for mass
shifts. Finally, since the same concentration would be
added to all lysates, the intensities of the proteins in the
lysates could be held relative to this standard, and these
relative intensities would be used to better ascertain
quantitative differences between lysates. This is in con-
trast to using absolute intensities, which may vary
based on chromatographic peak shape and source
cleanliness etc.
Conclusions
LC/MS characterization of Shigella and Escherichia dem-
onstrated greater specificity than obtainable using cur-
rent real-time PCR protocols, allowed for distinctions at
the strain level, and was less labor-intensive compared
with PFGE, the gold standard for subtyping bacteria.
Reproducible intact protein biomarker candidates were
observed and successfully implemented for the identi-
fication of unknown pathogens without the use of
primers, antibodies, or proteomic database searches.
This was of particular interest for Shigella speciation
for which PCR primers are commercially unavailable.
These protein biomarker candidates could be se-
quenced and used to reverse-engineer novel PCR prim-
ers [19–21]. Likewise, these biomarker candidates could
be purified for the production of antibodies to enhance
serological investigations (e.g., protein microarrays)
[22, 23].
Future work will include the expansion of the data-
base of bacteria that have been studied. Based on theproof of concept work described above this should be
quite straightforward. Statistical analysis such as prin-
ciple components or hierarchical cluster analysis of
LC/MS data may be investigated to asses their utility
for establishing similarity/strain relatedness between
known and unknown bacteria. Since submission, it was
determined that three repeat experiments provided
sufficient reproducibility for determining biomarker
candidates rather than five as reported here. Addition-
ally, a threefold increase in throughput was achieved
using ultra-performance liquid chromatography [24].
This work would add another dimension to an inte-
grated approach for more comprehensive bacterial
identification.
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